Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on mild cognitive impairment.

David A Bennett1

  • 1Rush Alzheimer's Disease Center, Rush Presbyterian-St. Luke's Medical Center, 1645 West Jackson Boulevard, Suite 675, Chicago, IL 60612, USA. dbennett@rush.edu

Current Neurology and Neuroscience Reports
|August 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans.

Molecular neurobiology·2016
Same author

Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.

Acta neuropathologica·2016
Same author

Addendum: REST and stress resistance in ageing and Alzheimer's disease.

Nature·2016
Same author

Association of cognitive activity and neurocognitive function in blacks and whites with HIV.

AIDS (London, England)·2016
Same author

The characteristics of astrocyte on Aβ clearance altered in Alzheimer's disease were reversed by anti-inflammatory agent (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate.

American journal of translational research·2016
Same author

Novel genetic loci underlying human intracranial volume identified through genome-wide association.

Nature neuroscience·2016
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Mild cognitive impairment (MCI) affects cognitive abilities without causing dementia. Research focuses on understanding MCI progression and preventing dementia development in affected individuals.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) describes individuals with noticeable cognitive decline, short of dementia.
  • MCI research has surged, with a significant increase in publications since 2001.
  • Despite evolving criteria, a consensus recognizes MCI's prevalence and association with mortality, morbidity, and Alzheimer's disease (AD) pathology.

Purpose of the Study:

  • To investigate the factors contributing to dementia development in individuals with MCI.
  • To explore intervention strategies for preventing dementia progression in MCI patients.

Main Methods:

  • Literature review and analysis of trends in MCI research publications.
  • Synthesis of emerging consensus on MCI criteria and associations.

Related Experiment Videos

  • Overview of current research directions in MCI and dementia prevention.

    • Main Results:

    • A substantial rise in scientific literature concerning MCI.
    • Growing agreement on MCI's commonality and its link to AD pathology.
    • MCI is associated with increased mortality and morbidity, particularly progression to AD.

    Conclusions:

    • MCI is a significant clinical concern, closely linked to Alzheimer's disease.
    • Ongoing research aims to elucidate MCI's progression pathways.
    • Intervention studies are crucial for preventing dementia in MCI populations.